SCHEMBL3640484

SCHEMBL3640484

CC(C)(C)OC(=O)c1[nH]c2ccc(Br)cc2c1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
RXFP1 Q9HBX9 2/20 0.51
PRNP P04156 1/20 0.51
PPARG P37231 1/20 0.51
HIF1A Q16665 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NR2E3 Q9Y5X4 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
ALOX12 P18054 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 1/20 0.42
CLK1 P49759 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960232 0.81 GAA (0.49) CYP1A2CYP2C9CYP2C19RXFP1PRNP
SCHEMBL30580683 0.81 KDM4E (0.54) MEN1KMT2AALDH1A1MAPTPOLB
SCHEMBL3095750 0.72 RXFP1 (0.68) CYP1A2CYP2C9CYP2C19RXFP1PRNP
SCHEMBL2150840 0.72 ALOX5 (0.40) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL6986880 0.71 NR4A2 (0.72) SMN1; SMN2GABRA1GABRA3NR4A2
SCHEMBL25301691 0.71 PRNP (0.50) CYP1A2CYP2C9CYP2C19RXFP1PRNP
SCHEMBL3001754 0.71 ALOX15 (0.62) CYP1A2CYP2C9CYP2C19RXFP1PRNP
SCHEMBL16306763 0.71 MAPT (0.57) CYP1A2CYP2C9CYP2C19RXFP1PRNP
SCHEMBL6049264 0.71 GABRA1 (0.51) NPSR1MEN1KMT2AALDH1A1GAA
SCHEMBL31424548 0.70 RXFP1 (0.65) CYP1A2CYP2C9CYP2C19RXFP1PRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176256-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2010-04-21 EP disclosed
WO-2009007751-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed